美国中心内血液透析患者远程医疗使用情况
本研究利用美国联邦医疗保险索赔数据,分析COVID-19疫情期间中心内血液透析患者使用远程医疗与肾脏科医生访视频率及住院的关联。发现远程医疗使用与每月至少四次访视率略高相关(发生率比1.014;95%CI 1.007-1.022),但与住院无显著关联,且在医生需长途出行才能面诊患者的地区关联更强。
要点
- 远程医疗使用与中心内血透患者每月≥4次肾脏科访视率略高相关。
- 远程医疗使用与住院风险无显著关联。
- 在医生需长途出行才能面诊患者的地区,远程医疗与访视频率关联更强。
核心结论
- 远程医疗用于中心内血液透析患者可略微提高每月至少四次访视的频率,但不影响住院风险。
- 在医生需长途出行才能面诊患者的地区,远程医疗与访视频率的关联更明显。
研究设计与样本
- 使用美国联邦医疗保险索赔数据,识别COVID-19疫情前16个月内接受中心内血液透析的患者。
- 纳入1881名明确使用远程医疗的肾脏科医生(2020年3月至2021年6月期间看诊患者)。
- 采用多变量回归模型,调整患者、医生、地理、透析机构特征及疫情前访视频率。
主要发现
- 调整模型中,机构远程医疗使用绝对增加35%(对应1个标准差差异)与每月至少四次访视率升高1.4%相关(发生率比1.014;95%CI 1.007-1.022)。
- 远程医疗使用与住院无显著关联。
- 远程医疗使用与访视频率的关联在到机构出行距离更远的地区更强(交互作用P=0.01)。
关键数值与推荐
- 远程医疗使用与每月至少四次访视率:发生率比1.014(95%CI 1.007-1.022)。
- 远程医疗使用与访视频率的交互作用P=0.01(按出行距离分层)。
临床怎么用
- 在中心内血液透析患者中,可考虑使用远程医疗作为面诊的替代方式以维持访视频率。
- 对于医生需长途出行才能面诊患者的地区,远程医疗可能更有助于提高访视频率。
局限性
- 研究为观察性设计,无法确定因果关系。
- 仅纳入明确使用远程医疗的肾脏科医生,可能存在选择偏倚。
- 未报告远程医疗使用与住院关联的具体效应值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Emergency waivers enacted during the coronavirus disease 2019 (COVID-19) pandemic in the United States enabled kidney care providers to provide hemodialysis visits with telemedicine. Telemedicine was associated with a somewhat higher frequency of four or more hemodialysis visits per month but not with hospitalizations. Visit frequency increases were more pronounced when kidney care providers had to travel longer distances to see patients in person. BACKGROUND: In March 2020, responding to the coronavirus disease 2019 (COVID-19) pandemic, federal emergency waivers in the United States enabled kidney care providers (nephrologists and advanced practice providers) to substitute face-to-face in-center hemodialysis visits with telemedicine encounters. We examined whether the frequency of kidney care provider visits and hospitalizations were associated with telemedicine use in hemodialysis care. METHODS: We used Medicare claims to identify US patients receiving in-center hemodialysis during the first 16 months of the COVID-19 pandemic. We examined the association between telemedicine use during in-center hemodialysis, the frequency with which kidney care providers visited patients at dialysis four or more times per month, and hospitalizations. We also examined whether the association between telemedicine use and visit frequency varied at facilities located in more remote areas. Multivariable regression models adjusted for patient, physician, geographic, and dialysis facility characteristics along with the frequency with which kidney care providers saw patients at each facility before the pandemic. We focused on kidney care providers who demonstrated knowledge of how to bill for telemedicine visits by using the telemedicine modifier on prior claims. RESULTS: We identified 1881 providers who saw patients between March 2020 and June 2021 and were definitively using telemedicine. In the adjusted model, a 35% absolute higher use of telemedicine at a facility (representing 1 SD difference) was associated with a 1.4% higher rate of four or more visits (incidence rate ratio, 1.014; 95% confidence interval, 1.007 to 1.022). The association between telemedicine use and visit frequency was stronger where travel distances to facilities were farther (interaction P = 0.01). There was no significant association between telemedicine use and hospitalizations. CONCLUSIONS: The use of telemedicine to care for patients receiving in-center hemodialysis was associated with a slightly higher frequency of four or more visits per month but not with hospitalizations; the association with visit frequency was more pronounced in areas where providers had to travel longer distances to see patients in person.
引用
- Niu J, Rosales O, Oluyomi A, et al. Utilization of Telemedicine for Patients Receiving In-Center Hemodialysis in the United States. J Am Soc Nephrol. 2025. PMID: 39819660. doi:10.1681/ASN.0000000619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。